(Q34552599)

3 August 2017

1 reference

title

Current status and future directions in the pharmacotherapy of epilepsy (English)

1 reference

3 August 2017

0 references

Wolfgang Löscher

1

1 reference

3 August 2017

publication date

1 March 2002

1 reference

Trends in Pharmacological Sciences

3 August 2017

published in

1 reference

3 August 2017

volume

23

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

113-118

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

3 August 2017

1 reference

7 January 2021

Emerging insights into the genesis of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Causes of epilepsy: contributions of the Rochester epidemiology project.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Advances in the medical treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

New anti-epileptic drugs for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Clinical aspects and biological bases of drug-resistant epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Do we need any more new antiepileptic drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Surgical treatment of epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

New visions in the pharmacology of anticonvulsion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Antiepileptogenic agents: how close are we?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

The process of epileptogenesis: a pathophysiological approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Identification and preclinical testing of novel antiepileptic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Responses to NMDA receptor antagonists altered by epileptogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Genetic susceptibility to adverse drug reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

The pharmacological basis of contemporary pain management

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Novel treatments for bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Kindling: separate vs. shared mechanisms in affective disorders and epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Patients with refractory seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Role of multidrug transporters in pharmacoresistance to antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Animal models of intractable epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilespy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Comparison of valproate and phenobarbital treatment after status epilepticus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Epilepsy-associated plasticity in gamma-aminobutyric acid receptor expression, function, and inhibitory synaptic properties

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Recent advances in the genetics of epilepsy: insights from human and animal studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Genetics of the epilepsies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Ion channels and epilepsy in man and mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

Detecting genes in new and old mouse models for epilepsy: a prospectus through the magnifying glass

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901974-X

7 January 2021

10.1016/S0165-6147(00)01974-X

Identifiers

DOI

1 reference

3 August 2017

1 reference